NCT06761677 2026-02-05
A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma
SymBio Pharmaceuticals
Phase 1/2 Suspended
Clinical Trials
9 trialsNCT05138458 2023-11-13
IMAGINE
Myeloid Therapeutics
Phase 1/2 Suspended
NCT03659669 2023-10-23
REVEAL
AbbVie
Suspended
NCT03229876 2023-07-24
Safety and Efficacy Evaluation of CD19-UCART
Bioray Laboratories
Phase NA Suspended
NCT01982175 2022-06-21
CLL004
Shanghai Zhangjiang Biotechnology Limited Company
Phase 2 Suspended
NCT03722186 2021-03-22
Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Suspended
NCT03381677 2020-08-03
POST
Innovative Surgical Designs
Phase NA Suspended
NCT02117336 2014-09-03
Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Piramal Enterprises Limited
Phase 1 Suspended
NCT00077493 2007-12-28
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
MedImmune LLC
Phase 1 Suspended